Stocks
AbbVie Inc.ABBV
NYSEHealthcarePharmaceuticals$219.68-2.52%
A large U.S. biopharmaceutical company focused on immunology, oncology, neuroscience, and aesthetics medicines. Its portfolio includes blockbuster drugs such as Skyrizi and Rinvoq, as well as Botox and other aesthetics products acquired through the Allergan deal. Investors closely watch the company ...
Market Cap: $388.4B52W Range: $164.39 – $244.81
Congressional Interest in AbbVie Inc. (ABBV)
13 members of Congress have disclosed 50 trades in AbbVie Inc. (ABBV), a Healthcare company. The buy/sell breakdown shows 21 purchases versus 29 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
13
Buys
21
Sells
29
Who in Congress Is Trading ABBV?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-01-10 | Rohit Khanna | sell | $1K – $15K |
| 2024-01-10 | Rohit Khanna | buy | $1K – $15K |